CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas

Archive ouverte

Tauziède-Espariat, Arnault | Nicaise, Yvan | Sievers, Philipp | Sahm, Felix | von Deimling, Andreas | Guillemot, Delphine | Pierron, Gaëlle | Duchesne, Mathilde | Edjlali, Myriam | Dangouloff-Ros, Volodia | Boddaert, Nathalie | Roux, Alexandre | Dezamis, Edouard | Hasty, Lauren | Lhermitte, Benoît | Hirsch, Edouard | Hirsch, Maria Paola Valenti | Ardellier, François-Daniel | Karnoub, Mélodie-Anne | Csanyi, Marie | Maurage, Claude-Alain | Mokhtari, Karima | Bielle, Franck | Rigau, Valérie | Roujeau, Thomas | Abad, Marine | Klein, Sébastien | Bernier, Michèle | Horodyckid, Catherine | Adam, Clovis | Brandal, Petter | Niehusmann, Pitt | Vannod-Michel, Quentin | Provost, Corentin | de Champfleur, Nicolas Menjot | Nichelli, Lucia | Métais, Alice | Mariet, Cassandra | Chrétien, Fabrice | Blauwblomme, Thomas | Beccaria, Kévin | Pallud, Johan | Puget, Stéphanie | Uro-Coste, Emmanuelle | Varlet, Pascale

Edité par CCSD ; BioMed Central part of Springer Science -

International audience. A novel methylation class, “neuroepithelial tumor, with PLAGL1 fusion” (NET-PLAGL1), has recently been described, based on epigenetic features, as a supratentorial pediatric brain tumor with recurrent histopathological features suggesting an ependymal differentiation . Because of the recent identification of this neoplastic entity, few histopathological, radiological and clinical data are available. Herein, we present a detailed series of nine cases of PLAGL1 -fused supratentorial tumors, reclassified from a series of supratentorial ependymomas, non- ZFTA/ non -YAP1 fusion-positive and subependymomas of the young. This study included extensive clinical, radiological, histopathological, ultrastructural, immunohistochemical, genetic and epigenetic (DNA methylation profiling) data for characterization. An important aim of this work was to evaluate the sensitivity and specificity of a novel fluorescent in situ hybridization (FISH) targeting the PLAGL1 gene. Using histopathology, immunohistochemistry and electron microscopy, we confirmed the ependymal differentiation of this new neoplastic entity. Indeed, the cases histopathologically presented as “mixed subependymomas-ependymomas” with well-circumscribed tumors exhibiting a diffuse immunoreactivity for GFAP, without expression of Olig2 or SOX10. Ultrastructurally, they also harbored features reminiscent of ependymal differentiation, such as cilia. Different gene partners were fused with PLAGL1 : FOXO1, EWSR1 and for the first time MAML2 . The PLAGL1 FISH presented a 100% sensitivity and specificity according to RNA sequencing and DNA methylation profiling results. This cohort of supratentorial PLAGL1 -fused tumors highlights: 1/ the ependymal cell origin of this new neoplastic entity; 2/ benefit of looking for a PLAGL1 fusion in supratentorial cases of non- ZFTA/ non -YAP1 ependymomas; and 3/ the usefulness of PLAGL1 FISH.

Suggestions

Du même auteur

Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions

Archive ouverte | Tauziède-Espariat, Arnault | CCSD

International audience. Abstract The cIMPACT-NOW Update 7 has replaced the WHO nosology of “ependymoma, RELA fusion positive” by “Supratentorial-ependymoma, C11orf95 -fusion positive”. This modification reinforces t...

Phenotypic and epigenetic heterogeneity in FGFR2 ‐fused glial and glioneuronal tumours

Archive ouverte | Métais, Alice | CCSD

International audience. Aims FGFR ‐fused central nervous system (CNS) tumours are rare and are usually within the glioneuronal and neuronal tumours or the paediatric‐type diffuse low‐grade glioma spectrum. Among thi...

An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB‐fused broadening the spectrum of tumor entities in comparison with their soft tissue counterparts

Archive ouverte | Tauziède‐espariat, Arnault | CCSD

International audience. FET:CREB fusions have been described in a variety of tumors from various phenotypes. Recently, these fusion transcripts were reported in intracranial tumors, variably named intracranial mesen...

Chargement des enrichissements...